AI assistant
Sending…
Applied Therapeutics, Inc. — Director's Dealing 2024
Aug 23, 2024
34263_dirs_2024-08-23_a9b2b337-47da-4de0-adfd-02f49e896c1f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2024-08-22
Reporting Person: Funtleyder Leslie D. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-22 | Common Stock | S | 13530 | $5.83 | Disposed | 277911 | Direct |
Footnotes
F1: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
More from Applied Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Delisting Announcement
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3